Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

NASDAQ:MIRO

Miromatrix Medical Inc.

Last Close

3.37

12/12 21:00

Market Cap

92.95M

Beta: -

Volume Today

631.56K

Avg: 57.52K

PE Ratio

−3.41

PFCF: −3.79

Filings Not Available